QQ客服 官方微博 反馈留言

	Safety and Incidence of Cardiovascular Events in Chinese Patients with Acute Coronary Syndrome Treated with Ticagrelor: the 12-Month, Phase IV, Multicenter, Single-Arm DAYU Study
	Gao, Runlin; Wu, Yongjian; Liu, Hengliang; Su, Guohai; Yuan, Zuyi; Zhang, Aidong; Wang, Yong; Wang, Zhirong; Wang, Yan; Zhang, Huanyi
刊名	CARDIOVASCULAR DRUGS AND THERAPY
	2018
卷号	32页码:47-56
关键词	Ticagrelor Chinese patients Safety Acute coronary syndrome
ISSN号	0920-3206
URL标识	查看原文
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/2918127
专题	西安交通大学
推荐引用方式 GB/T 7714	Gao, Runlin,Wu, Yongjian,Liu, Hengliang,et al. Safety and Incidence of Cardiovascular Events in Chinese Patients with Acute Coronary Syndrome Treated with Ticagrelor: the 12-Month, Phase IV, Multicenter, Single-Arm DAYU Study[J]. CARDIOVASCULAR DRUGS AND THERAPY,2018,32:47-56.
APA	Gao, Runlin.,Wu, Yongjian.,Liu, Hengliang.,Su, Guohai.,Yuan, Zuyi.,...&Han, Yaling.(2018).Safety and Incidence of Cardiovascular Events in Chinese Patients with Acute Coronary Syndrome Treated with Ticagrelor: the 12-Month, Phase IV, Multicenter, Single-Arm DAYU Study.CARDIOVASCULAR DRUGS AND THERAPY,32,47-56.
MLA	Gao, Runlin,et al."Safety and Incidence of Cardiovascular Events in Chinese Patients with Acute Coronary Syndrome Treated with Ticagrelor: the 12-Month, Phase IV, Multicenter, Single-Arm DAYU Study".CARDIOVASCULAR DRUGS AND THERAPY 32(2018):47-56.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。